Biomarkers for kidney damage should speed drug development

Drug-safety indicators are the first fruits of a collaboration between academia, industry and regulators.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Dieterle, F. et al. Nature Biotechnol. 28, 463-469 (2010).
Article CAS Google Scholar
Vaidya, V. S. et al. Nature Biotechnol. 28, 478-485 (2010).
Article CAS Google Scholar
Yu, Y. et al. Nature Biotechnol. 28, 470-477 (2010).
Article CAS Google Scholar
Ozer, J. S. et al. Nature Biotechnol. 28, 486-494 (2010).
Article CAS Google Scholar

Authors

Brendan Borrell
View author publications
You can also search for this author in PubMed Google Scholar

Borrell, B. Biomarkers for kidney damage should speed drug development. Nature (2010). https://doi.org/10.1038/news.2010.232